SCHEMBL13699097

SCHEMBL13699097

CN1CC23CCC2[C@H](Oc2ccc(C(=O)O)cc2)CC13

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRD5A2 P31213 1/20 0.39
ALDH1A1 P00352 1/20 0.38
LMNA P02545 1/20 0.38
CASP3 P42574 1/20 0.38
SENP8 Q96LD8 1/20 0.38
SENP6 Q9GZR1 1/20 0.38
TDP1 Q9NUW8 1/20 0.38
EPHX2 P34913 6/20 0.37
SRD5A1 P18405 1/20 0.35
MMP13 P45452 1/20 0.35
CA1 P00915 1/20 0.35
CA2 P00918 1/20 0.35
USP2 O75604 1/20 0.35
RXRA P19793 1/20 0.34
RXRB P28702 1/20 0.34
RXRG P48443 1/20 0.34
KDM1A O60341 2/20 0.34
CYP26A1 O43174 1/20 0.34
CYP3A4 P08684 1/20 0.34
CYP26B1 Q9NR63 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13699104 0.72 SRD5A2 (0.40) SRD5A2ALDH1A1LMNACASP3SENP8
SCHEMBL8437114 0.70 ALDH1A1 (0.56) SRD5A2ALDH1A1LMNACASP3SENP8
SCHEMBL4240205 0.69 CHRM2 (0.59) EPHX2
SCHEMBL13699322 0.68 EPHX2 (0.43) SRD5A2ALDH1A1LMNACASP3SENP8
SCHEMBL4236560 0.65 SLC6A2 (0.67) SRD5A2ALDH1A1LMNACASP3SENP8
SCHEMBL5703742 0.64 EPHX2 (0.49) SRD5A2ALDH1A1LMNACASP3SENP8
SCHEMBL27516126 0.64 ALDH1A1 (0.49) SRD5A2ALDH1A1LMNACASP3SENP8
SCHEMBL3458790 0.64 SRD5A1 (0.59) SRD5A2ALDH1A1LMNACASP3SENP8
SCHEMBL1028676 0.64 EPHX2 (0.68) SRD5A2ALDH1A1LMNACASP3SENP8
SCHEMBL11755572 0.64 PARP10 (0.71) SRD5A2ALDH1A1LMNACASP3SENP8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090233910-A1 Npy antagonists, preparation and uses CEREP (FR) 2009-09-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090233910-A1 Npy antagonists, preparation and uses NPY1R, NPY5R, NPY2R SRD5A2 2351/4885ALDH1A1 4542/4885LMNA 2227/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.